{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-015131","form_type":"8-K","ticker":"NRC","cik":"0000070487","company_name":"NRC HEALTH","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.719990+00:00","generated_at":"2026-06-02T21:14:54.930454+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"medium","headline":"NRC Health appoints Linda Stacy as PFO; Q1 dividend $0.12; $40M net debt; no GAAP results disclosed","bullets":["Linda Stacy appointed Principal Financial Officer effective May 7, 2024; retains roles as PAAO and Secretary.","Quarterly cash dividend of $0.12/share declared, payable July 15, 2024 to holders of record June 28, 2024.","Q1 2024 returned $18M to stockholders via dividends and share repurchases; $4M invested in innovation.","Net debt ~$40M; available liquidity includes $23M line of credit and $56M delayed draw term facility.","Press release provides no GAAP revenue or EPS figures; CEO cites upcoming AI features and expanded product suite."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-015131","json":"https://secwatch.observer/filing/0001437749-24-015131.json","markdown":"https://secwatch.observer/filing/0001437749-24-015131.md","text":"https://secwatch.observer/filing/0001437749-24-015131.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70487/000143774924015131/0001437749-24-015131-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70487/000143774924015131/nrc20240506_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T21:14:54.930454+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4d7cff0134","claim":"Linda Stacy was appointed as Principal Financial Officer at NRC HEALTH.","evidence_excerpt":"On May 7, 2024, the Company’s Board of Directors appointed Linda Stacy as the Company’s Principal Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774924015131/0001437749-24-015131-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}